Recurrent lymphocytic meningitis positive for herpes simplex virus type 2. 2009

Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
Helsinki University Central Hospital, Helsinki, Finland. katariina.kallio-laine@helsinki.fi

We found the prevalence of recurrent lymphocytic meningitis associated with herpes simplex virus type 2 (HSV-2) was 2.2/100,000 population in Finland during 1996-2006, higher than previous estimates. PCR was most sensitive in detecting HSV-2 DNA from cerebrospinal fluid if the sample was taken 2-5 days after symptom onset.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008216 Lymphocytic Choriomeningitis A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3) Armstrong Syndrome,Armstrong's Syndrome,Encephalomyelitis, Lymphocytic Choriomeningitis Virus,Lymphocytic Choriomeningitis Virus Encephalomyelitis,Choriomeningitis, Lymphocytic,Syndrome, Armstrong,Syndrome, Armstrong's
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006558 Herpes Genitalis Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females. Genital Herpes,Herpes Simplex, Genital,Herpes Simplex Virus Genital Infection,Genital Herpes Simplex,Herpes, Genital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D018258 Herpesvirus 2, Human A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. HSV-2,Herpes Simplex Virus 2,Human Herpesvirus 2,HHV-2,Herpes Simplex Virus Type 2,Herpesvirus 2 (alpha), Human

Related Publications

Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
January 2019, Medicina,
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
March 2009, Revista clinica espanola,
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
January 2022, Proceedings (Baylor University. Medical Center),
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
January 2004, The Journal of the American Board of Family Practice,
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
January 2004, Lancet (London, England),
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
January 2016, Revista clinica espanola,
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
June 2004, Military medicine,
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
November 2005, The Journal of infection,
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
April 1994, Presse medicale (Paris, France : 1983),
Katariina Kallio-Laine, and Mikko Seppänen, and Hannu Kautiainen, and Marja Liisa Lokki, and Maija Lappalainen, and Ville Valtonen, and Markus Färkkilä, and Eija Kalso
June 2010, Archives of neurology,
Copied contents to your clipboard!